Development and evaluation of a decision aid for HPV vaccination among adults aged 27–45 years old in the United States

被引:0
|
作者
Wheldon, Christopher W. [1 ]
Grace, Jessica [2 ,6 ]
Zimet, Gregory [3 ]
Daley, Ellen M. [4 ]
Akpan, Idara N. [2 ]
Alkhatib, Sarah A. [2 ]
Thompson, Erika L. [2 ,5 ]
机构
[1] Department of Social & Behavioral Sciences, College of Public Health, Temple University, 1301 Cecil B. Moore Ave., Philadelphia,PA,19122, United States
[2] Department of Population and Community Health, School of Public Health, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth,TX,76107, United States
[3] Department of Population and Community Health, School of Public Health, Pediatrics, Indiana University School of Medicine and Zimet Research Consulting LLC, 1625 Sturbridge Road, Indianapolis,IN,46260, United States
[4] College of Public Health, University of South Florida, Tampa, FL, 13201 Bruce B. Downs Blvd, MDC 56, Tampa,FL,33612, United States
[5] Department of Quantitative and Qualitative Health Sciences, University of Texas School of Public Health San Antonio, University of Texas Health Science Center at San Antonio, 8403 Floyd Curl Drive, San Antonio,TX,78229, United States
[6] Department of Social Work, College of Health and Public Service, University of North Texas, 410 Ave. C, Denton,TX,76201, United States
关键词
D O I
10.1016/j.compbiomed.2024.109557
中图分类号
学科分类号
摘要
Objective: To design, develop, and field test the HPV Decide decision tool to facilitate shared clinical decision-making recommendation for mid-adult HPV vaccination. Methods: The ‘HPV Decide’ online tool was developed through a 6-step process, involving community and provider advisory boards, usability testing with 10 end users (unvaccinated adults aged 27–45), field testing interviews with another 10, and interviews with 18 healthcare providers. The process incorporated both inductive and deductive qualitative data analyses. Results: The logic model, based on the Ottawa Decision Support Framework, highlighted the importance of objective knowledge and managing decisional conflict. Iterative modifications were informed by the advisory boards, alpha testing, and usability testing. Field testing showed utility to end users, highlighting the straightforward design, and lack of medical jargon. Many expressed a desire to access the tool before doctor appointments, emphasizing its value in a healthcare context and in partnership with providers. Lastly, healthcare provider feedback highlighted information quality, structure, acceptability, and future implementation. Discussion: While users recognized the tool's information quality and user-centric design, full evaluation focused on changes in informed decision making and clinic-based implementation are needed. Practical value: The HPV Decide decision tool demonstrates promise in supporting informed decisions about HPV vaccination among mid-adults. © 2024 Elsevier Ltd
引用
收藏
相关论文
共 50 条
  • [1] Correlates of HPV Vaccination Intentions Among Adults Ages 27-45 Years Old in the US
    Thompson, Erika L.
    Garg, Ashvita
    Galvin, Annalynn M.
    Moore, Jonathan D.
    Kasting, Monica L.
    Wheldon, Christopher W.
    JOURNAL OF COMMUNITY HEALTH, 2021, 46 (05) : 893 - 902
  • [2] Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27-45 years in the United States
    Gidengil, Courtney A.
    Parker, Andrew M.
    Markowitz, Lauri E.
    Gedlinske, Amber M.
    Askelson, Natoshia M.
    Petersen, Christine A.
    Meites, Elissa
    Lindley, Megan C.
    Scherer, Aaron M.
    VACCINE, 2023, 41 (16) : 2650 - 2655
  • [3] Awareness and knowledge of HPV and HPV vaccination among adults ages 27-45 years
    Thompson, Erika L.
    Wheldon, Christopher W.
    Rosen, Brittany L.
    Maness, Sarah B.
    Kasting, Monica L.
    Massey, Philip M.
    VACCINE, 2020, 38 (15) : 3143 - 3148
  • [4] Correlates of HPV Vaccination Intentions Among Adults Ages 27–45 Years Old in the U.S.
    Erika L. Thompson
    Ashvita Garg
    Annalynn M. Galvin
    Jonathan D. Moore
    Monica L. Kasting
    Christopher W. Wheldon
    Journal of Community Health, 2021, 46 : 893 - 902
  • [5] Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among adults aged 27-45 years in the United States
    Osazuwa-Peters, Nosayaba
    Rincon, Natalie
    McDowell, Kelsey Rae
    Ritchwood, Tiarney
    Boakye, Eric Adjei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [6] Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years
    Rincon, Natalie L.
    McDowell, Kelsey Rae
    Weatherspoon, Darien
    Ritchwood, Tiarney D.
    Rocke, Daniel J.
    Boakye, Eric Adjei
    Osazuwa-Peters, Nosayaba
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [7] Comment on "Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years"
    Zaidi, Abdul Rehman Zia
    Alghalyini, Baraa
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [8] Incomplete HPV vaccination among individuals aged 27-45 years in the United States: A mixed effect analysis of individual and contextual factors.
    Adekanmbi, Victor
    Guo, Fangjian
    Hsu, Christine
    Kuo, Yong-Fang
    Berenson, Abbey
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Incomplete HPV Vaccination among Individuals Aged 27-45 Years in the United States: A Mixed-Effect Analysis of Individual and Contextual Factors
    Adekanmbi, Victor
    Guo, Fangjian
    Hsu, Christine D. D.
    Shan, Yong
    Kuo, Yong-Fang
    Berenson, Abbey B. B.
    VACCINES, 2023, 11 (04)
  • [10] Factors Associated with HPV Vaccination Among Middle-Aged Adults in the United States
    Gallagher, Tyler J.
    Chwa, Jason
    Lin, Matthew E.
    Kokot, Niels C.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024,